Prognostic factors in patients with post-transplant lymphoproliferative disorders (PTLD) in the rituximab era

Leukemia and Lymphoma - Tập 46 Số 2 - Trang 191-196 - 2005
Irene M. Ghobrial1, Thomas M. Habermann, Kay M. Ristow, Stephen M. Ansell, William R. Macon, Suzan M Geyer, Christopher G.A. McGregor
1Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA.

Tóm tắt

Từ khóa


Tài liệu tham khảo

Durandy A, 2001, Transpl Infect Dis, 3, 104, 10.1034/j.1399-3062.2001.003002104.x

10.1097/00007890-199911270-00015

10.1182/blood.V99.7.2592

10.1097/00007890-200110270-00012

Coiffier B, 2003, Blood Rev, 17, 25, 10.1016/S0268-960X(02)00059-0

10.1016/S0140-6736(99)02058-9

Habermann TM, 1999, Hosp Pract (Off Ed), 34, 81, 10.3810/hp.1999.12.178

Walker RC, 1995, Clin Infect Dis, 20, 1346, 10.1093/clinids/20.5.1346

Leblond V, 2001, J Clin Oncol, 19, 772, 10.1200/JCO.2001.19.3.772

Tsai DE, 2001, Transplantation, 71, 1076, 10.1097/00007890-200104270-00012

Muti G, 2002, Haematologica, 87, 67

Nalesnik MA, 2002, Recent Results Cancer Res, 159, 9, 10.1007/978-3-642-56352-2_2

Nelson BP, 2000, Am J Surg Pathol, 24, 375, 10.1097/00000478-200003000-00006

Oertel S, 2000, Transplantation, 69, 430, 10.1097/00007890-200002150-00021

McGuirk J, 1999, Bone Marrow Transplant, 24, 1253, 10.1038/sj.bmt.1702052

10.1016/S0168-8278(00)80406-7

Milpied N, 2000, Ann Oncol, 11, 113, 10.1023/A:1008372814223

10.1056/NEJMoa011795

Thông tin
Thông tin xuất bản

Leukemia and Lymphoma

Tập 46 Số 2

191-196

Thông tin tác giả